                               SEQUENCE LISTING

<110> SAREPTA THERAPEUTICS, INC.
      MASSACHUSETTS INSTITUTE OF TECHNOLOGY
 
<120> BICYCLIC PEPTIDE OLIGONUCLEOTIDE CONJUGATES

<130> 606055: SPT-009PC

<140> PCT/US2018/056178
<141> 2018-10-17

<150> 62/573,473
<151> 2017-10-17

<160> 9    

<170> PatentIn version 3.5

<210> 1
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Cys Arg Arg Arg Arg Arg Arg Cys Arg Arg Arg Arg Arg Arg Cys 
1               5                   10                  15  


<210> 2
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Cys Arg Arg Arg Cys Arg Arg Arg Cys 
1               5                   


<210> 3
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Cys Arg Arg Arg Arg Arg Arg Cys Cys Arg Arg Arg Arg Arg Arg Cys 
1               5                   10                  15      


<210> 4
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Arg Arg Arg Arg Arg Arg Cys Cys Arg Arg Arg Arg Arg Arg 
1               5                   10                  


<210> 5
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10          


<210> 6
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Cys Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Cys 
1               5                   10                  


<210> 7
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
gctattacct taacccag                                                     18


<210> 8
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(9)
<223> Cys or Arg

<220>
<221> MISC_FEATURE
<222> (2)..(9)
<223> This region may encompass 3-8 residues

<220>
<221> MOD_RES
<222> (12)..(19)
<223> Cys or Arg

<220>
<221> MISC_FEATURE
<222> (12)..(19)
<223> This region may encompass 3-8 residues

<400> 8
Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys Cys Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Cys 
            20  


<210> 9
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(7)
<223> Cys or Arg

<220>
<221> MOD_RES
<222> (10)..(15)
<223> Cys or Arg

<400> 9
Cys Xaa Xaa Xaa Xaa Xaa Xaa Cys Cys Xaa Xaa Xaa Xaa Xaa Xaa Cys 
1               5                   10                  15      

